Target intelligence / Profile preview

microRNA 451a (miR-451a)

Target
miR-451a
Molecular classification
Non-coding RNA, microRNA, Other
01

Overview

microRNA 451a (miR-451a) is a highly conserved, short (~22 nucleotide) non-coding RNA belonging to the microRNA family, encoded by the MIR451A gene on human chromosome 17. Unlike canonical microRNAs, miR-451a undergoes an unusual biogenesis pathway that is Dicer-independent and instead is processed directly by Ago2 from its precursor hairpin[1][3][2]. It plays major roles in the post-transcriptional regulation of gene expression, serving critical biological functions in erythropoiesis, hematopoietic differentiation, immune modulation, cell proliferation, and apoptosis[1][5]. miR-451a is extensively studied as a tumor suppressor in diverse malignancies, although it can function as an oncogene in certain contexts such as renal cell carcinoma, depending on the tissue and target gene landscape[4][6]. It is emerging as a promising therapeutic target and biomarker in cancer and immune diseases, but challenges remain regarding off-target effects and tissue-specific activity[4][5][6].

Other names
MIR451Ahsa-mir-451amiR-451MIR451MIRN451hsa-mir-451mir-451amicroRNA 451
02

Mechanism of action

Modulation of miR-451a expression (via mimics or inhibitors) alters gene expression post-transcriptionally, affecting cell proliferation, apoptosis, drug resistance, and tumorigenesis[4][2][6].

03

Biological functions

Post-transcriptional gene regulationApoptosisCell proliferationCell deathErythropoiesisHematopoietic differentiationImmune regulationTumor suppression
04

Disease associations

CancerInflammationImmune-related diseaseRenal cell carcinomaOther
05

Safety considerations

Off-target effects of miRNA-based therapeuticsPotential tissue-specific effects/contradictory functions (tumor suppressor vs. oncogene in different cancers)Broad regulatory impact on gene networks
06

Interacting drugs

None clearly established (modulators or mimetics may be under exploration in preclinical studies but no approved drugs target miR-451a directly)
07

Biomarkers

Diagnostic/prognostic biomarker in multiple cancers (RCC, basal cell carcinoma, gastric and colorectal cancer)Biomarker for immune-related diseases

Beyond the preview

Go deeper on microRNA 451a (miR-451a).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 451a (miR-451a).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call